Cargando…
PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer
Gastric cancer (GC) is a major health burden worldwide, but our understanding of GC is limited, and the prognosis is poor. Novel therapeutic strategies and biomarkers are urgently needed to improve GC patient outcomes. Previously, we identified PFDN2 as a novel key gene in gastric cancer based on it...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395514/ https://www.ncbi.nlm.nih.gov/pubmed/37538116 http://dx.doi.org/10.3389/fonc.2023.1164070 |